Straus D - Search Results

1

Prognostic significance of baseline metabolic tumor volume in relapsed and refractory Hodgkin lymphoma.

Moskowitz AJ, Schöder H, Gavane S, Thoren KL, Fleisher M, Yahalom J, McCall SJ, Cadzin BR, Fox SY, Gerecitano J, Grewal R, Hamlin PA, Horwitz SM, Kumar A, Matasar M, Ni A, Noy A, Palomba ML, Perales MA, Portlock CS, Sauter C, Straus D, Younes A, Zelenetz AD, Moskowitz CH. Moskowitz AJ, et al. Among authors: straus d. Blood. 2017 Nov 16;130(20):2196-2203. doi: 10.1182/blood-2017-06-788877. Epub 2017 Sep 5. Blood. 2017. PMID: 28874350 Free PMC article.

2

Four cycles of chemotherapy and regional radiation therapy for clinical early-stage and intermediate-stage Hodgkin's disease.

Straus DJ, Yahalom J, Gaynor J, Myers J, Koziner B, Caravelli J, Lee BJ 3rd, Nisce LZ, McCormick B, Bajorunas D, et al. Straus DJ, et al. Cancer. 1992 Feb 15;69(4):1052-60. doi: 10.1002/1097-0142(19920215)69:4<1052::aid-cncr2820690437>3.0.co;2-9. Cancer. 1992. PMID: 1370915 Clinical Trial.

3

Prognostic factors among 185 adults with newly diagnosed advanced Hodgkin's disease treated with alternating potentially noncross-resistant chemotherapy and intermediate-dose radiation therapy.

Straus DJ, Gaynor JJ, Myers J, Merke DP, Caravelli J, Chapman D, Yahalom J, Clarkson BD. Straus DJ, et al. J Clin Oncol. 1990 Jul;8(7):1173-86. doi: 10.1200/JCO.1990.8.7.1173. J Clin Oncol. 1990. PMID: 1694235 Clinical Trial.

4

Mitoxantrone, etoposide, mitoguazone and vinblastine chemotherapy (MV2) in relapsed and refractory lymphomas.

Crown JP, Gulati S, Straus DJ, Kolitz J, Heelan R, O'Brien J, Lee BJ, Portlock C, Bertino J. Crown JP, et al. Among authors: straus dj. Invest New Drugs. 1991 May;9(2):185-6. doi: 10.1007/BF00175086. Invest New Drugs. 1991. PMID: 1874601 Clinical Trial.

5

Diffuse large cell lymphoma. Prognostic factors with treatment.

Straus DJ, Wong G, Yahalom J, Varsos G, Gulati S, Clarkson B. Straus DJ, et al. Leukemia. 1991;5 Suppl 1:32-7. Leukemia. 1991. PMID: 1890863 Clinical Trial.

6

Impact of adjuvant radiation on the patterns and rate of relapse in advanced-stage Hodgkin's disease treated with alternating chemotherapy combinations.

Yahalom J, Ryu J, Straus DJ, Gaynor JJ, Myers J, Caravelli J, Clarkson BD, Fuks Z. Yahalom J, et al. Among authors: straus dj. J Clin Oncol. 1991 Dec;9(12):2193-201. doi: 10.1200/JCO.1991.9.12.2193. J Clin Oncol. 1991. PMID: 1960560 Clinical Trial.

7

High-risk Hodgkin's disease prognostic factors.

Straus DJ. Straus DJ. Leuk Lymphoma. 1995;15 Suppl 1:41-2. doi: 10.3109/10428199509052704. Leuk Lymphoma. 1995. PMID: 7767259 Review. No abstract available.

8

Modern treatment approaches for Hodgkin's disease.

Straus DJ. Straus DJ. Curr Opin Oncol. 1993 Sep;5(5):785-90. doi: 10.1097/00001622-199309000-00003. Curr Opin Oncol. 1993. PMID: 8218490 Review.

9

Adjuvant cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy after radiation therapy in stage I low-grade and intermediate-grade non-Hodgkin lymphoma. Results of a prospective randomized study.

Yahalom J, Varsos G, Fuks Z, Myers J, Clarkson BD, Straus DJ. Yahalom J, et al. Among authors: straus dj. Cancer. 1993 Apr 1;71(7):2342-50. doi: 10.1002/1097-0142(19930401)71:7<2342::aid-cncr2820710728>3.0.co;2-i. Cancer. 1993. PMID: 8453557 Clinical Trial.

10

Treatment of early stage Hodgkin's disease.

Straus DJ. Straus DJ. Blood Rev. 1993 Mar;7(1):34-42. doi: 10.1016/0268-960x(93)90022-v. Blood Rev. 1993. PMID: 8467230 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

560 results

Search Page

Filters